Laboratory testing for Zika virus infection Interim guidance - 23 March 2016

The recent increase in cases of microcephaly and other neurological disorders potentially associated with Zika virus infection has prompted an increase in demand for laboratory testing to detect Zika virus infection. Groups prioritized for diagnostic testing should be symptomatic individuals and asymptomatic pregnant women with possible exposure to Zika virus. This document provides guidance on current testing strategies for Zika virus infection. This document will be reviewed and updated as additional information becomes available.

This interim guidance is for use by staff of laboratories testing for Zika virus infection and for clinical practitioners and public health professionals providing clinical management or surveillance.